|
|
|||||||
|
|
|
||||||
|
Molecular Pathology
Laboratory |
|||||||
|
Al-Mulla
|
Patients' information |
Doctors' information |
Students' Material |
Literature |
Contact us | ||
| Our laboratory | | |||||||
|
Welcome Wordle of our research focus |
![]() The Molecular Pathology Laboratory was established in 2000 in an attempt to study, diagnose and understand diseases at the molecular level specifically utilizing the uniqueness of the Arabian genome for this purpose. |
||||
![]() |
|||||
|
|
New Discoveries from our laboratory |
Using haplotype mapping we were able to identify genomic sites linked to metastatic behaviour in colorectal cancer. These regions are now being refined and mapped at high resolution to identify the genes involved. On this front we have identified RKIP (PEBP1) Raf Kinas Inhibitory Protein, as an independent marker for metastasis and reduced survival. Moreover, we found RKIP to be the only marker to date to be able to detect patients with early colorectal caner that relapse with metastasis. We now offer our patented "METASTASIS PREDICTION" method for detecting patients with bad prognosis. The test is mainly applied to early stage (Dukes' A and B) colorectal cancer to predict, with high accuracy, metastatic relapse.
We have recently found yet another reason why cells become resistant to chemotherapy when RKIP is lost or diminished in expression. |
|||
|
|
|||||
|
|
|||||
|
Copyright al-mulla.org© 2012 |
|
||||